NavDx FAQ

NavDx^TM is a liquid biopsy blood test that detects Human Papilloma Virus (HPV)-associated head and neck cancers in patients
NavDx^TMhas been demonstrated to detect early recurrences in patients before they would be identified in current clinical practice
NavDx^TMmeasures fragments of DNA shed by cancers cells in the blood
NavDx^TM is intended to provide information to clinicians with a more precise understanding the status of the disease recurrence which helps in making decisions on current and future therapy.

There are five distinct applications of NavDx^TM (1) guided selection of targeted- and immuno-therapies, (2) prognosis of the likely course and outcome of disease for individual patients, (3) early detection of cancer in asymptomatic individuals, (4) real time monitoring of patient responses to therapy, and 5) monitoring patients in remission for the development of recurrence.

For patients who previously received a cancer diagnosis, we use a blood sample collected by your doctor to detect cancers using specialized genetic fingerprints of your cancer.

For patients who previously received a cancer diagnosis, we use a blood sample collected by your doctor to detect cancers using specialized genetic fingerprints of your cancer.

To learn more, please email us at contact@naveris.com or complete the form below.